Genesis Global Group
Genesis Drug Discovery & Development
GD3

You will now be redirected to the GD3 website

Genesis Drug Discovery & Development is a proud member of Genesis Drug Discovery & Development (GD3), a fully integrated CRO providing services to support drug discovery programs of our clients from target discovery through IND filing and managing Phase I-III clinical trials.

Learn more about GD3
Search

Biochemistry & Bioanalytical

AAV Packaging

Adeno-associated Virus (AAV) Cloning and Packaging Services

The adeno-associated virus (AAV) has gained prominence as a crucial viral vector in both gene and cell therapy applications. Our team specializes in providing comprehensive AAV cloning and packaging services, meticulously tailored to support your research goals. Whether for small-scale in vitro experiments or large-scale packaging for pre-clinical animal studies, our expertise ensures success across different research phases with services such as:

  • Vector Design and Cloning: We leverage our expertise in helper-free systems to create custom AAV vectors that precisely match your specific requirements.
  • AAV Production and extraction with qPCR titration: Our state-of-the-art facilities enable us to produce high-quality AAV vectors in quantities suitable for both small-scale in vitro studies and large-scale pre-clinical animal models.
  • In Vitro Characterization: We offer a range of in vitro assays to assess the functionality and transduction efficiency of your AAV vectors.
  • Functional Readout Assay Development: Our team can assist in developing tailored functional readout assays to measure the biological effects of your gene of interest.
Figure 1. Left, image showing map of helper-free system cloning vector with GFP and luciferase reporters. Right, graph showing luciferase activity in cells after successful AAV production, extraction, and infection.